中国组织工程研究 ›› 2012, Vol. 16 ›› Issue (8): 1391-1395.doi: 10.3969/j.issn.1673-8225.2012.08.014

• 材料生物相容性 material biocompatibility • 上一篇    下一篇

注射型可吸收聚氨基酸/硫酸钙复合材料动物体内的安全及组织相容性*☆

邹  昌1,张  帅1,段  宏1,闵  理1,周  勇1,屠重棋1,严永刚2,裴福兴1   

  1. 1四川大学华西医院骨科,四川省成都市  610041;  2四川国纳科技有限公司,四川省成都市  610041
  • 收稿日期:2011-07-11 修回日期:2011-08-17 出版日期:2012-02-19 发布日期:2012-02-19
  • 通讯作者: 屠重棋,教授,博士生导师,四川大学华西医院骨科,四川省成都市 610041 tuchongqi@ 163.com
  • 作者简介:邹昌☆,男,1987 年生,湖南省衡阳市人,汉族,四川大学华西临床医学院在读博士,主要从事骨肿瘤诊断及治疗的研究。 ciciboylove@ 163.com
  • 基金资助:

    国家科技部支撑计划项目(2007BAE13B04),课题名称:活性纳米复合材料制品应用开发—活性纳米复合材料制品手术示范与临床应用。

Security and biocompatibility of injectable absorbable poly amino acid/calcium sulfate composites in vivo  

Zou Chang1, Zhang Shuai1, Duan Hong1, Min Li1, Zhou Yong1, Tu Chong-qi1, Yan Yong-gang2, Pei Fu-xing1   

  1. 1Department of Orthopedics, West China Hospital of Sichuan University, Chengdu  610041, Sichuan Province, China; 2National Nanotechnology Co., Ltd., Chengdu  610041, Sichuan Province, China
  • Received:2011-07-11 Revised:2011-08-17 Online:2012-02-19 Published:2012-02-19
  • Contact: Tu Chong-qi, Professor, Doctoral supervisor, Department of Orthopedics, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China tuchongqi@163.com
  • About author:Zou Chang☆, Studying for doctorate, Department of Orthopedics, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China ciciboylove@ 163.com
  • Supported by:

     the Support Program of National Science and Technology Ministry, No. 2007BAE13B04*

摘要:

背景:临床上应用的聚甲基丙烯酸甲酯和磷酸钙骨水泥可注射型骨修复材料在体内不能完全降解、吸收,且成骨能力较差。
目的:评估新注射型聚氨基酸/硫酸钙复合材料在动物体内的安全性及组织相容性。
方法:将注射型聚氨基酸/硫酸钙复合材料植入新西兰兔背部肌肉内,将其浸提液分别注射至昆明小鼠体内与新西兰兔背部皮内。
结果与结论:注射材料浸提液后,小鼠一般情况良好,体质量均呈上升趋势,腹腔各脏器无明显水肿、粘连、坏死等;兔背部浸提液注射部位未出现红斑、水肿等皮内刺激反应。聚氨基酸/硫酸钙复合材料植入兔背部肌肉早期材料周围炎症反应明显,后逐渐减弱,包膜样结构逐渐被吸收,未见明显排斥反应;材料周围肌肉细胞色素氧化酶和乳酸脱氢酶等氧化相关酶活性无明显减弱。提示新型可注射复合材料在动物体内具有良好的安全性和组织相容性。

关键词: 氨基酸聚合物, 硫酸钙, 可注射人工骨, 可吸收人工骨, 体内相容性, 动物实验

Abstract:

BACKGROUND: Injectable bone repair materials such as polymethylmethacrylateand calcium phosphate cement cannot be completely degraded or absorbed in clinical application, and both of them have poor osteogenic ability.
OBJECTIVE: To evaluate the security and biocompatibility of injectable absorbable poly amino acid/calcium sulfate through animal experiments.
METHODS: The composite materials were implanted into the musculus sacrospinalis of New Zealand rabbits, and the diffusion solution was injected into Kunming mice and the back skin of New Zealand rabbits, respectively.
RESULTS AND CONCLUSION: The general condition of mice were good after the injection of the diffusion solution, and the body weight was increasing, without significant edema, adhesions, necrosis of intra-abdominal organs. The skin stimulation reactions such as erythema and edema were not observed after the injection of the diffusion solution into the rabbits. The inflammatory reaction around the implants was obvious after intramuscular implantation into the rabbits in the early stage, and then weakened gradually. The capsule-like structure was also absorbed gradually, and no significant rejection was observed. The activity of cytochrome oxidase and lactate dehydrogenase of muscles cells around the implants had no significant decrease after implantation. All of the above prompted that the new poly amino acid/calcium sulfate composites have good biocompatibility and excellence safety in vivo.

中图分类号: